头颈重建中游离皮瓣血管危象的发生率与危险因素:一项Meta分析
既往放疗(OR=3.98)、液体超负荷(OR=2.57)、手术时间延长(OR=2.14)等是不可忽视的危险因素,结果支持将可调控生理指标纳入术前风险分层。
要点
- 皮瓣血管危象合并发生率为8.2%,完全失败率为3.9%。
- 既往放疗是显著危险因素(OR=3.98),需加强术前评估。
- 液体超负荷、手术时间长等可调控因素与皮瓣危象显著相关。
核心结论
- 游离皮瓣血管危象仍是头颈重建中临床意义显著的并发症。
- 研究结果支持将可调控生理指标整合到术前风险分层中,并实施针对性的多学科优化策略以改善皮瓣结局。
研究设计与样本
- 系统检索PubMed、MEDLINE、Embase、Cochrane Library和Web of Science截至2025年9月1日的文献。
- 遵循PRISMA指南的Meta分析,由两名独立评审者筛选文献、提取数据并使用Newcastle-Ottawa量表(NOS)评估研究质量。
- 采用随机效应模型计算合并发生率及比值比(OR)和95%置信区间(CI)。
主要发现
- 皮瓣血管危象的合并发生率为8.2%(95% CI:6.6%-9.9%)。
- 完全失败率为3.9%(95% CI:3.2%-4.7%)。
- 既往放疗与皮瓣血管危象显著相关(OR=3.98)。
- 其他显著不可调控因素包括糖尿病(OR=2.20)、高龄(OR=1.35)和高合并症评分(OR=1.68)。
- 可调控因素包括液体超负荷(OR=2.57)、手术时间延长(OR=2.14)、低血清白蛋白(OR=2.06)、低BMI(OR=1.75)和低血红蛋白(OR=1.34)。
关键数值与推荐
- 皮瓣血管危象合并发生率8.2%(95% CI:6.6%-9.9%),完全失败率3.9%(95% CI:3.2%-4.7%)。
- 既往放疗OR=3.98,糖尿病OR=2.20,高龄OR=1.35,高合并症评分OR=1.68。
- 液体超负荷OR=2.57,手术时间延长OR=2.14,低血清白蛋白OR=2.06,低BMI OR=1.75,低血红蛋白OR=1.34。
临床怎么用
- 术前应评估既往放疗史、糖尿病、高龄及合并症评分以进行风险分层。
- 围手术期优化可调控因素,如避免液体超负荷、缩短手术时间、纠正低白蛋白、低BMI和低血红蛋白。
- 建议采用多学科协作策略以降低皮瓣血管危象风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Microvascular free flap reconstruction is the gold standard for head and neck defects, but flap compromise remains a primary cause of reconstructive failure. This study aims to evaluate the pooled incidence of flap compromise and total flap failure, and to identify risk factors to optimize perioperative management. DATA SOURCES: A systematic search was conducted across PubMed, MEDLINE, Embase, the Cochrane Library, and Web of Science for studies published up to September 1, 2025. REVIEW METHODS: This meta-analysis followed the PRISMA guidelines. Two independent reviewers screened the literature, extracted data, and assessed study quality using the Newcastle-Ottawa Scale (NOS). Random-effects models were used to calculate pooled incidences and odds ratios (ORs) with 95% confidence intervals (CIs). RESULTS: Forty-seven studies involving 30,002 free flaps were included. The pooled incidence of flap compromise was 8.2% (95% CI: 6.6%-9.9%), with a complete failure rate of 3.9% (95% CI: 3.2%-4.7%). Flap compromise was significantly associated with prior radiotherapy (OR = 3.98). Other significant non-modifiable factors included diabetes (OR = 2.20), advanced age (OR = 1.35), and high comorbidity scores (OR = 1.68). Importantly, several modifiable factors were identified as critical drivers, including fluid overload (OR = 2.57), prolonged operative time (OR = 2.14), low serum albumin (OR = 2.06), low BMI (OR = 1.75), and low hemoglobin (OR = 1.34). CONCLUSION: Free flap compromise remains a clinically significant complication. These findings support integrating modifiable physiological markers into preoperative risk stratification and implementing targeted, multidisciplinary optimization strategies to improve flap outcomes.
引用
- Xiao Y, Lin Y, Li E, et al. Incidence and Risk Factors for Free Flap Compromise in Head and Neck Reconstruction: A Meta-Analysis. Otolaryngol Head Neck Surg. 2026. PMID: 42647048. doi:10.1002/ohn.70404
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。